Cargando...
Fluorescence-guided Resection of Experimental Malignant Glioma Using Cetuximab-IRDye 800CW
The standard treatment for Glioblastoma Multiforme (GBM) remains maximal safe surgical resection. Here, we evaluated the ability of a systemically administered antibody-dye probe conjugate (cetuximab-IRDye 800CW) to provide sufficient fluorescent contrast for surgical resection of disease in both su...
Guardado en:
| Publicado en: | Br J Neurosurg |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4740249/ https://ncbi.nlm.nih.gov/pubmed/26073144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02688697.2015.1056090 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|